Evenity and Speech impairment (adult) - a phase IV clinical study of FDA data

Summary:

Speech impairment (adult) is reported as a side effect among people who take Evenity (romosozumab-aqqg), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cortril, and have Osteoporosis.

The phase IV clinical study analyzes which people have Speech impairment (adult) when taking Evenity. It is created by eHealthMe based on reports of 9,472 people who have side effects when taking Evenity from the FDA, and is updated regularly.

What is Evenity?

Evenity has active ingredients of romosozumab-aqqg. eHealthMe is studying from 9,485 Evenity users. Check the latest studies of Evenity.

What is Speech impairment (adult)?

Speech impairment (adult) (inability to speak (adult)) is found to be associated with 2,140 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Speech impairment (adult).

On Jul, 15, 2026

9,472 people reported to have side effects when taking Evenity.
Among them, 18 people (0.19%) have Speech impairment (adult).

Could Evenity cause Speech impairment (adult)?

Among these 18 people:

How long have people been on Evenity when they have Speech impairment (adult)? *

What is the gender of people who have Speech impairment (adult) when taking Evenity? *

female: 100 %
male: 0.0 %

What is the age of people who have Speech impairment (adult) when taking Evenity? *

What are other drugs people take besides Evenity? *

What are other side effects people have besides Speech impairment (adult)? *

Headache (pain in head): 8 people, 44.44%
Depressed Level Of Consciousness: 4 people, 22.22%
Pain: 4 people, 22.22%
Weight Decreased: 3 people, 16.67%
Swallowing Difficulty: 3 people, 16.67%
Brain Neoplasm (tumour of brain): 3 people, 16.67%
Injection Site Swelling: 3 people, 16.67%
Itching: 3 people, 16.67%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 16.67%
Throat Irritation: 2 people, 11.11%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 12 people, 66.67%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 16.67%
Parkinson's Disease: 2 people, 11.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.11%
High Blood Cholesterol: 2 people, 11.11%
Depression: 2 people, 11.11%
Atherosclerosis (disorder of the arteries): 2 people, 11.11%
High Blood Pressure: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Evenity and have Speech impairment (adult)?

- Check whether Speech impairment (adult) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evenity:

Evenity (9,485 reports)

Browse all side effects of Evenity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech impairment (adult):

Speech impairment (adult) (2,140 drugs)

Browse all the conditions that are associated with Speech impairment (adult):

Speech impairment (adult) (3,591 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on romosozumab-aqqg (the active ingredients of Evenity) and Evenity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.